These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28552464)

  • 1. Nurse-led vaccination program dramatically improves pneumococcal vaccination coverage among patients with autoimmune inflammatory disorders.
    Serre J; François C; der Haegen MCV; Papo T; Goulenok T; Sacre K
    Eur J Intern Med; 2017 Sep; 43():e43-e45. PubMed ID: 28552464
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact on vaccination coverage following introduction of a routine pneumococcal vaccination programme for the elderly in Japan.
    Shono A; Hoshi SL; Kondo M
    Vaccine; 2018 Sep; 36(39):5886-5890. PubMed ID: 30143271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pneumococcal infections and vaccination in patients with systemic autoimmune and/or inflammatory diseases].
    Duchet-Niedziolka P; Hanslik T; Aouba A; Le Guern V; Guillevin L; Launay O;
    Presse Med; 2009 Feb; 38(2):243-50. PubMed ID: 19046848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination status and factors associated with pneumococcal vaccination in geriatric short-stay care].
    Bourderont A; Lafont C; Descatoire P; Tandé D; Meurant A; Bourderont D; Villain C
    Soins Gerontol; 2024; 29(167):38-45. PubMed ID: 38677810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S.
    Petigara T; Zhang D
    Am J Prev Med; 2018 May; 54(5):630-636. PubMed ID: 29551328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the national routine vaccination program on 23-valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan.
    Naito T; Yokokawa H; Watanabe A
    J Infect Chemother; 2018 Jun; 24(6):496-498. PubMed ID: 29398479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases.
    Broyde A; Arad U; Madar-Balakirski N; Paran D; Kaufman I; Levartovsky D; Wigler I; Caspi D; Elkayam O
    J Rheumatol; 2016 Feb; 43(2):267-72. PubMed ID: 26773117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Loubet P; Kernéis S; Groh M; Loulergue P; Blanche P; Verger P; Launay O
    Vaccine; 2015 Jul; 33(31):3703-8. PubMed ID: 26073016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria.
    Andrews RM; Skull SA; Byrnes GB; Campbell DA; Turner JL; McIntyre PB; Kelly HA
    Commun Dis Intell Q Rep; 2005; 29(3):283-8. PubMed ID: 16220865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New recommendations for pneumococcal vaccination in patients with autoimmune and inflammatory diseases.
    Hernández-Flórez D; González-Benítez R; Valor L
    Med Clin (Barc); 2017 Feb; 148(4):181-183. PubMed ID: 27931862
    [No Abstract]   [Full Text] [Related]  

  • 11. Pneumococcal vaccination: effective in children under the age of 2 years.
    Prescrire Int; 2009 Dec; 18(104):266. PubMed ID: 20027709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus document on pneumococcal vaccination in adults with risk underlying clinical conditions].
    Picazo JJ; González-Romo F; García Rojas A; Peréz-Trallero E; Gil Gregorio P; de la Cámara R; Morató ML; Rodríguez A; Barberán J; Domínguez Hernández V; Linares Rufo M; Jimeno Sanz I; Portolés JM; Sanz Herrero F; Espinosa Arranz J; García-Sánchez V; Galindo Izquierdo M
    Rev Esp Quimioter; 2013 Sep; 26(3):232-52. PubMed ID: 24080892
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
    Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O
    Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 4. Health care for the elderly and vaccination: Current situation of pneumococcal vaccines and pneumococcal diseases].
    Oishi K
    Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2247-51. PubMed ID: 27522786
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatricians' perspectives on the use of pneumococcal vaccine in healthy and asthmatic children.
    Karakaş T; Şahiner UM; Soyer OU; Civelek E; Cokugras H; Şekerel BE
    Allergol Immunopathol (Madr); 2010; 38(5):241-5. PubMed ID: 20656396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against pneumococcal infection in adults].
    Viejo JL
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():26-8. PubMed ID: 20084346
    [No Abstract]   [Full Text] [Related]  

  • 17. A collaborative program to increase adult pneumococcal vaccination rates among a high-risk patient population receiving care at urgent care clinics.
    Lehman N; Koenigsfeld CF; Wall GC; Renner C; Hahn D; Sheesley B; Veach LA; Bjornson A
    Am J Infect Control; 2018 Aug; 46(8):952-953. PubMed ID: 29661629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight years of active proposal of pneumococcal 23-valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients.
    Martinelli D; Tafuri S; Caputi G; Fortunato F; Reggio P; Germinario C; Prato R
    Am J Infect Control; 2010 May; 38(4):e8-e15. PubMed ID: 20211508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
    Giese C; Mereckiene J; Danis K; O'Donnell J; O'Flanagan D; Cotter S
    Vaccine; 2016 Jul; 34(32):3657-62. PubMed ID: 27255466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
    Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
    Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.